Vimarsana
Biggest News Aggregation in the World

Page 3 - Mark Chin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Chin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Chin Today - Breaking & Trending Today

Bill would curb 'implicit bias' training in Tennessee schools, universities - Vimarsana News

Bill would curb 'implicit bias' training in Tennessee schools, universities

Tennessee public schools and universities would not be allowed to require employees to take "implicit bias" training under legislation filed this week by two state lawmakers.

Ensoma Raises $85M in Series B Funding; Acquires Twelve Bio - Vimarsana News

Ensoma Raises $85M in Series B Funding; Acquires Twelve Bio

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Ensoma buys a startup to advance 'in vivo' cell therapy work - Vimarsana News

Ensoma buys a startup to advance 'in vivo' cell therapy work

BioPharma

Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Update - Vimarsana News

Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Update

Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 479,800 shares, a growth of 37.9% from the May 15th total of 347,900 shares. Approximately 2.2% of the company’s shares are short sold. Based […]

Pyxis Oncology (NASDAQ:PYXS) Cut to Sell at Zacks Investment Research - Vimarsana News

Pyxis Oncology (NASDAQ:PYXS) Cut to Sell at Zacks Investment Research

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.